A Life Course Approach to Investigating Asthma Pathogenesis and Progression

研究哮喘发病机制和进展的生命全程方法

基本信息

  • 批准号:
    G0900453-E01/1
  • 负责人:
  • 金额:
    $ 275.04万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2009
  • 资助国家:
    英国
  • 起止时间:
    2009 至 无数据
  • 项目状态:
    已结题

项目摘要

Asthma is the commonest chronic lung disease in the UK. It affects all age groups and significantly impacts on quality of life, schooling and work. For most it requires lifelong treatment with drugs and uncertainty, due to the variable nature of the disease. Little is known how factors initiate the disease in early life or impact over the life course of the disease. This programme is centred on studying the life course of asthma, focusing on underlying mechanisms that may lead to disease persistence and progression and how different environmental factors exert influence.Our research focuses on the human asthma and involves sampling the airways to evaluate on-going tissue events and to obtain airway cells that can be studied in the laboratory under different conditions of exposure. We believe that the airways lining (epithelium) plays a major role in interacting with the environment and, in asthma, expresses signals that promote abnormal inflammation within the airways and induce structural changes (scarring) that alters their flexibility. We have called this dynamic interaction between the epithelium and the deeper airway wall structures the Epithelial Mesenchymal Trophic Unit (EMTU). Our research focuses on understanding how this EMTU is activated in asthma of differing severity and stages of disease. Recognising that most asthma has its origin in the first few years of life, undergoes major changes during childhood and adolescence in which over half ?grow out? of their diseases and adopts characteristics of becoming irreversible in some adults, we have constructed our 5 year programme in 3 stages: (i) In young children at the onset of disease we will use our cell culture systems in the presence and absence of virus, allergen and tobacco smoke exposure to seek differences in the way the epithelium communicates with underlying cells in the EMTU; ii) In teenagers from our Isle of Wight cohort, that has been extensively characterised in relationship to asthma from birth to the age of 18 years, we will assess activation of the EMTU in those with persistent asthma and those who have ?grown out? of asthma; and (iii) In adults with established asthma we determine how the scarring affects the stiffness of the airway wall and whether repeated airway narrowing contributes to and can account for the loss of treatment response in such asthmatics.This research will identify much needed new targets in disease prevention and treatment high up in the causal disease pathways.
哮喘是英国最常见的慢性肺部疾病。它影响到所有年龄组,并对生活质量、学校教育和工作产生重大影响。对于大多数人来说,由于疾病的可变性质,它需要终身药物治疗和不确定性。很少有人知道这些因素如何在生命早期引发疾病或影响疾病的生命过程。该项目的重点是研究哮喘的生命过程,重点是可能导致疾病持续和发展的潜在机制,以及不同的环境因素如何发挥影响。我们的研究重点是人类哮喘,包括采样气道以评估正在进行的组织事件,并获得气道细胞,可以在实验室中在不同的暴露条件下进行研究。我们认为,气道衬里(上皮)在与环境的相互作用中起着重要作用,在哮喘中,表达促进气道内异常炎症的信号,并诱导改变其灵活性的结构变化(瘢痕形成)。我们将上皮和更深的气道壁结构之间的这种动态相互作用称为上皮间充质营养单位(EMTU)。我们的研究重点是了解EMTU如何在不同严重程度和疾病阶段的哮喘中被激活。认识到大多数哮喘起源于生命的最初几年,在儿童和青春期经历了重大变化,其中超过一半?长大了吗他们的疾病的特点,并采取成为不可逆的一些成年人,我们已经建立了我们的5年计划分3个阶段:(i)在幼儿发病时,我们将使用我们的细胞培养系统在存在和不存在病毒,过敏原和烟草烟雾暴露,以寻求上皮细胞与EMTU中的底层细胞沟通的方式的差异; ii)在我们的怀特岛队列的青少年中,从出生到18岁,已经广泛表征了与哮喘的关系,我们将评估持续性哮喘患者和患有哮喘的患者的EMTU激活情况。长大了吗哮喘;以及(iii)在已确诊的成人哮喘患者中,我们确定瘢痕形成如何影响气道壁的硬度,以及反复气道狭窄是否有助于并可以解释此类哮喘患者治疗反应的丧失。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen Holgate其他文献

Efficacy of omalizumab in allergic asthma patients at high-risk for asthma-related death
  • DOI:
    10.1016/s0091-6749(02)81596-2
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jean Bousquet;Stephen Holgate;Howard Fox;Jeen Liu;Jordi Castellsague
  • 通讯作者:
    Jordi Castellsague
Clearing the air: Assessing healthcare professionals' awareness of air pollution's health consequences
  • DOI:
    10.1016/j.fhj.2024.100130
  • 发表时间:
    2024-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Lydia Holtgrewe;Dahye Yoon;Christopher Johnes;Stephen Holgate;Lia Orlando;James Bevan;Yasmin Choudhury;Charlotte Soan;Thomas Daniels
  • 通讯作者:
    Thomas Daniels
Inhaled corticosteroid dose-reducing effect of omalizumab in patients with controlled, severe asthma according to usage of inhaled long-acting beta-agonists
  • DOI:
    10.1016/s0091-6749(02)81861-9
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Kian Fan Chung;Stephen Holgate;John O'Brien;Howard Fox;Jackie Thirlwell
  • 通讯作者:
    Jackie Thirlwell
Maintenance of Skills, Competencies, and Performance in Allergy and Clinical Immunology: Time to Lay the Foundation for a Universal Approach
  • DOI:
    10.1097/wox.0b013e31825546b4
  • 发表时间:
    2012-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Todor A. Popov;Dennis Ledford;Richard Lockey;Ruby Pawankar;James T. Li;Hae Sim Park;Werner Pichler;Noel Rodriguez Perez;Paolo Tassinari;Fulvio Braido;Sami Bahna;Dirceu Solé;Connie Katelaris;Stephen Holgate; on behalf of the World Allergy Organization Education Council
  • 通讯作者:
    on behalf of the World Allergy Organization Education Council
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING THE SAFETY AND EFFICACY OF ETANERCEPT 25 TWICE WEEKLY IN PATIENTS WITH SEVERE PERSISTENT ASTHMA
  • DOI:
    10.1378/chest.132.4_meetingabstracts.436b
  • 发表时间:
    2007-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Stephen Holgate;Michael Noonan;Pascal Chanez;William Busse;Lieven Dupont;Harold Nelson;Ian Pavord;Auli Hakulinen;Laurence Paolozzi;Lawrence McDermott;Joseph Wajdula
  • 通讯作者:
    Joseph Wajdula

Stephen Holgate的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen Holgate', 18)}}的其他基金

Wave 2 support for SPF Clean Air Champions - "Addressing the Challenge of the Indoor/Outdoor Continuum"
对 SPF 清洁空气冠军的第二波支持 - “应对室内/室外连续体的挑战”
  • 批准号:
    NE/X004236/1
  • 财政年份:
    2022
  • 资助金额:
    $ 275.04万
  • 项目类别:
    Research Grant
Application for Strategic Priorities Fund: Clean Air Champion
战略优先基金申请:清洁空气冠军
  • 批准号:
    NE/T002069/1
  • 财政年份:
    2019
  • 资助金额:
    $ 275.04万
  • 项目类别:
    Research Grant

相似国自然基金

运用Life-course方法纵向研究婴幼儿龋发病危险因素
  • 批准号:
    30872875
  • 批准年份:
    2008
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目

相似海外基金

An Integrated Life-course Approach for Person-centred Solutions and Care for Ageing with Multi-morbidity in the European Regions - STAGE; Stay Healthy Through Ageing
欧洲地区以人为本的解决方案和针对多种疾病的老龄化护理的综合生命全程方法 - STAGE;
  • 批准号:
    10112787
  • 财政年份:
    2024
  • 资助金额:
    $ 275.04万
  • 项目类别:
    EU-Funded
An Integrated Life-Course Approach for Person-Centred Solutions and Care for Ageing with Multimorbidity in the European Regions - STAGE; Stay Healthy Through Ageing (STAGE)
欧洲地区以人为本的解决方案和多病态老龄化护理的综合生命全程方法 - STAGE;
  • 批准号:
    10109957
  • 财政年份:
    2024
  • 资助金额:
    $ 275.04万
  • 项目类别:
    EU-Funded
A life course approach to explore the social determinants of noncommunicable diseases risks in rural Vietnam
采用生命全程方法探索越南农村非传染性疾病风险的社会决定因素
  • 批准号:
    22KJ3162
  • 财政年份:
    2023
  • 资助金额:
    $ 275.04万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
A life course approach to understanding ADHD among women
了解女性多动症的生命历程方法
  • 批准号:
    MR/X02220X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 275.04万
  • 项目类别:
    Research Grant
ChildLives - Family complexity and inequalities in children's lives in Europe: A child-centred life course approach
ChildLives - 欧洲家庭的复杂性和儿童生活的不平等:以儿童为中心的生命历程方法
  • 批准号:
    EP/Y036441/1
  • 财政年份:
    2023
  • 资助金额:
    $ 275.04万
  • 项目类别:
    Research Grant
An intersectional and life course approach to loneliness in middle-aged and older adults: generating evidence for tailored and equitable action
解决中老年人孤独感的跨生命历程方法:为采取量身定制的公平行动提供证据
  • 批准号:
    494122
  • 财政年份:
    2023
  • 资助金额:
    $ 275.04万
  • 项目类别:
    Operating Grants
Improving the adoption and sustainability of evidence-based policies: A life course approach to reducing diet-related NCDs in adolescents
提高循证政策的采用和可持续性:减少青少年饮食相关非传染性疾病的生命全程方法
  • 批准号:
    MR/Y008480/1
  • 财政年份:
    2023
  • 资助金额:
    $ 275.04万
  • 项目类别:
    Research Grant
A minimally invasive stable-isotope approach to determine nutrient handling across the life-course.
一种微创稳定同位素方法,用于确定整个生命过程中的营养处理。
  • 批准号:
    2747743
  • 财政年份:
    2022
  • 资助金额:
    $ 275.04万
  • 项目类别:
    Studentship
A Life Course Approach to Identify Risks of Hospitalization in Older Adults with Heart Failure
识别患有心力衰竭的老年人住院风险的生命全程方法
  • 批准号:
    10341651
  • 财政年份:
    2022
  • 资助金额:
    $ 275.04万
  • 项目类别:
Exploring minority ethnic doctors' career transitions in medicine: a life course approach
探索少数民族医生的医学职业转型:生命历程方法
  • 批准号:
    ES/W009420/1
  • 财政年份:
    2022
  • 资助金额:
    $ 275.04万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了